France· FR:67541600
HYPERIUM 1 mg, comprimé
A medicinal product containing rilménidine (dihydrogénophosphate de), registered in France by LES LABORATOIRES SERVIER, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RILMÉNIDINE (DIHYDROGÉNOPHOSPHATE DE)
- Manufacturer
- LES LABORATOIRES SERVIER
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
2 priced- cip133400932946921plaquette(s) polyamide PVC-Aluminium de 30 comprimé(s)EUR 4.65
- cip133400937225731plaquette(s) polyamide PVC-Aluminium de 90 comprimé(s)EUR 13.08
- cip133400955833833plaquette(s) polyamide PVC aluminium de 100 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rilménidine (dihydrogénophosphate de) in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRILMENIDIN TEVATeva Pharmaceuticals CR, s.r.o., Praha
- PolandRilmenidine GrindeksAS Grindeks
- United KingdomHyperium 1mg tabletsImported (France)
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Iterium, Rilmenidin Grindeks
- Bulgaria · Рилменидин Гриндекс, Рилменикс
- Czechia · Rilmenidin Teva, Rilmenidine Grindeks
- Estonia · Rilmenidine Grindeks
- Hungary · Hyperlex, Rilmenidin Teva
- Lithuania · Rilmenidine Grindeks, Rilmenidine Teva
- Luxembourg · Hyperium
- Latvia · Rilmenidine Grindeks, Rilmenidine Teva
- Poland · Rilmenidine Grindeks, Tenaxum
- Portugal · Hyperium, Rilmenidina Grindeks
- Romania · Rilmenidină Grindeks, Taruza
- Slovakia · Rilmenidin Teva, Rilmenidine Grindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2fc08ad7-0c21-4e87-a659-5bb89a63b649 GET /v1/drugs/2fc08ad7-0c21-4e87-a659-5bb89a63b649?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67541600",
"date_amm": "1987-04-23",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "RILMÉNIDINE (DIHYDROGÉNOPHOSPHATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about rilménidine (dihydrogénophosphate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.